Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $10.5400 (0%) ($10.4500 - $11.3500) on Wed. Jun. 17, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.27% (three month average) | RSI | 45 | Latest Price | $10.5400(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 1.3% a day on average for past five trading days. | Weekly Trend | ATRA declines -4.4% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -4.135% in a week (0% probabilities). VIXM(-33%) VXX(-28%) UUP(-10%) UNG(-10%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.135% (StdDev 8.27%) | Hourly BBV | 0 () | Intraday Trend | -0.2% | | | |
|
1 - 5 Day Possible Target | $-18.34(-274%) | Resistance Level | $10.98 | 5 Day Moving Average | $9.97(5.72%) | 10 Day Moving Average | $9.99(5.51%) | 20 Day Moving Average | $10.98(-4.01%) | To recent high | -29.4% | To recent low | 85.2% | Market Cap | $783m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |